Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma von Zweegman, Sonja, van der Holt, Bronno, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard M.J., Levin, Mark-David, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette W.G., Deenik, Wendy, Gruber, Astrid, Coenen, Juleon L.L.M., Plesner, Torben, Klein, Saskia K., Tanis, Bea C., Szatkowski, Damian L., Brouwer, Rolf E., Westerman, Matthijs, Leys, M.(Rineke) B.L., Sinnige, Harm A.M., Haukås, Einar, van der Hem, Klaas G., Durian, Marc F., Mattijssen, E.(Vera)J.M., van de Donk, Niels W.C.J., Stevens-Kroef, Marian J.P.L., Sonneveld, Pieter, Waage, Anders

Volltext

Improving the identification of frail elderly newly diagnosed multiple myeloma patients von Stege, Claudia A. M., Nasserinejad, Kazem, Klein, Saskia K., Timmers, Gert-Jan, Hoogendoorn, Mels, Ypma, Paula F., Nijhof, Inger S., Velders, Gerjo A., Strobbe, Leonie, Durdu-Rayman, Nazik, Westerman, Matthijs, Davidis-van Schoonhoven, Marjan A., van Kampen, Roel J. W., Beeker, Aart, Koster, Ad, Dijk, Amanda C., van de Donk, Niels W. C. J., van der Spek, Ellen, Leys, Rineke B. L., Silbermann, Matthijs H., Groen, Kaz, van der Burg-de Graauw, Nicole C. H. P., Sinnige, Harm A. M., van der Hem, Klaas G., Levenga, Henriette, Bilgin, Yavuz M., Sonneveld, Pieter, Levin, Mark-David, Zweegman, Sonja

Volltext

Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B‐cell lymphomas, determined by a highly sensitive in vitro apoptosis... von Cillessen, Saskia A.G.M., Meijer, Chris J.L.M., Ossenkoppele, Gert J., Castricum, Kitty C.M., Westra, August H., Niesten, Petra, Muris, Jettie J.F., Nijdam, Hoite F., Van Der Hem, Klaas G., Flens, Marcel, Hooijberg, Erik, Oudejans, Joost J.

Volltext

Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma von van Agthoven, M, Kramer, MH, Sonneveld, P, van der Hem, KG, Huijgens, PC, Wijermans, PW, Kluin-Nelemans, HC, Schaafsma, MR, Biesma, DH, Mattijssen, V, Uyl-de Groot, CA, Hagenbeek, A

Volltext

research paper: Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in... von Cillessen, Saskia AGM, Meijer, Chris JLM, Ossenkoppele, Gert J, Castricum, Kitty CM, Westra, August H, Niesten, Petra, Muris, Jettie JF, Nijdam, Hoite F, van der Hem, Klaas G, Flens, Marcel, Hooijberg, Erik, Oudejans, Joost J

Volltext

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a... von Nielsen, Lene Kongsgaard, Stege, Claudia, Lissenberg-Witte, Birgit I, van der Holt, Bronno, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard, Levin, Mark-David, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette W.G, Deenik, Wendy, Coenen, Juleon, Hinge, Maja, Klein, Saskia K, Tanis, Bea C, Szatkowski, Damian Lukasz, Brouwer, Rolf E, Westerman, Matthijs, Leys, Rineke, Sinnige, Harm A.M, Haukås, Einar, van der Hem, Klaas G, Durian, Marc F, Gimsing, Peter, van de Donk, Niels, Sonneveld, Pieter, Waage, Anders, Abildgaard, Niels, Zweegman, Sonja

Volltext bestellen

Bryostatin-5 stimulates normal human hematopoiesis and inhibits proliferation of HL60 leukemic cells von van der Hem, Klaas G., Dräger, Angelika M., Odding, Joan H., Langenhuijsen, Mart M.A.C., Huijgens, Peter C.

Volltext

Effects of bryostatin-5 and hematopoietic growth factors on acute myeloid leukemia cell differentiation, proliferation, and primary plating efficiency von van der Hem, Klaas G., Dräger, Angelika M., Odding, Joan H., Huijgens, Peter C.

Volltext

Heterogenous effects of bryostatin on human myeloid leukemia clonogenicity: Dose and time scheduling dependency von Van der Hem, Klaas G., Schuurhuis, Gerrit Jan, Dräger, Angelika M., Odding, Joan H., Huijgens, Peter C.

Volltext

Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group von Stege, Claudia A.M., van der Holt, Bronno, Mellqvist, Ulf-Henrik, Levin, Mark-David, Salomo, Morten, Abildgaard, Niels, Bos, Gerard, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette, Deenik, Wendy, Gruber, Astrid, Coenen, Jules L.L.M., Plesner, Torben, Klein, Saskia, Tanis, Bea, Szatkowski, Damian L., Brouwer, Rolf, Westerman, Matthijs, Leijs, Maria Berhardina, Sinnige, Harm, Haukaas, Einar, van der Hem, Klaas, Durian, Marc, Mattijssen, Vera, Gimsing, Peter, Van De Donk, Niels WCJ, Stevens-Kroef, Marian, Sonneveld, Pieter, Waage, Anders, Zweegman, Sonja

Volltext

Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide... von Zweegman, Sonja, Holt, Bronno van der, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard M.J., Levin, Mark-David, Visser-Wisselaar, Heleen A, Hansson, Markus, van der Velden, Annette WG, Deenik, Wendy, Gruber, Astrid, Coenen, Juleon LLM, Plesner, Torben, Klein, Saskia K, Tanis, Bea, Szatkowski, Damian L, Brouwer, Rolf, Westerman, Matthijs, Leys, M (Rineke) BL, van de Donk, Niels W.C.J., Haukås, Einar, van der Hem, Klaas, Durian, MF, Mattijssen, E (Vera) JM, Sinnige, Harm AM, Stevens-Kroef, Marian JPL, Sonneveld, Pieter, Waage, Anders

Volltext

Toward individual prognosis of IgA nephropathy von Beukhof, Johan R., Kardaun, Otto, Schaafsma, Willem, Poortema, Klaas, Donker, AbJ. M., Hoedemaeker, Philip J., van der Hem, Gjalt K.

Volltext